The Summary
This narrative review synthesized experimental and clinical studies exploring the microbiome-gut-brain axis in migraine patients. The research links migraines to intestinal dysbiosis, leaky gut, and systemic inflammation. Modulating the gut using probiotics (primarily Lactobacillus and Bifidobacterium strains), prebiotics, and postbiotics can strengthen the gut barrier and alter neuroinflammatory pathways. Clinical trials demonstrate that these biotics show promising signs of reducing migraine frequency, pain severity, and medication use. While these results are highly encouraging, researchers emphasize that larger, standardized placebo-controlled trials are necessary to determine optimal dosages and formulations.
Why this is interesting
Traditionally viewed as purely neurological, this review highlights how migraines are deeply connected to digestive health. By revealing that gut imbalance can trigger brain inflammation, it shifts how we approach headache prevention. For the millions suffering from chronic migraines, this means that targeted, low-risk dietary interventions—like specific probiotic and prebiotic supplements—could become powerful tools to reduce painful flare-ups and decrease reliance on heavy pain medications. It empowers patients with a practical, natural strategy to manage their symptoms from the inside out.